TMDX Research and Charts

TMDX - TransMedics Group Inc (Healthcare: Medical Devices)

Projected Earnings Date: 2025-01-26 (Delayed quote data 2025-01-06)

Last 75.63	Change ⇑ +6.54 (+9.47%)	Volume 3,281,697
	Open 71.97	High 76.57	Low 71.75

8EMA (Daily) 66.94	40EMA (Daily) 76.47	50EMA (Daily) 81.43	STO (Daily) 59.043	MACD Hist (Daily) 4.821
8EMA (Weekly) 74.812	40EMA (Weekly) 104.20	50EMA (Weekly) 103.78	STO (Weekly) 7.178	MACD Hist (Weekly) -7.815


Company Profile
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.